These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12545948)

  • 21. Postmenopausal hormone therapy and the risk of breast cancer: the view of an epidemiologist.
    Li CI
    Maturitas; 2004 Sep; 49(1):44-50. PubMed ID: 15351095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sobering data on alcohol and breast cancer.
    Willett WC; Stampfer MJ
    Epidemiology; 1997 May; 8(3):225-7. PubMed ID: 9115012
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of oral contraceptives, alcohol, and risk for invasive breast cancer.
    Dumeaux V; Lund E; Hjartåker A
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1302-7. PubMed ID: 15298950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Louwman WJ et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97-106.
    Dören M
    Cancer Causes Control; 2008 Nov; 19(9):1001. PubMed ID: 18409010
    [No Abstract]   [Full Text] [Related]  

  • 26. Exploring the links between breast cancer and oestrogen.
    Wall A
    Community Nurse; 1998 Oct; 4(9):27-8. PubMed ID: 10326369
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk of breast cancer among French-Canadian women, noncarriers of more frequent BRCA1/2 mutations and consumption of total energy, coffee, and alcohol.
    Bissonauth V; Shatenstein B; Fafard E; Maugard C; Robidoux A; Narod S; Ghadirian P
    Breast J; 2009; 15 Suppl 1():S63-71. PubMed ID: 19775332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived risk of breast cancer among women at average and increased risk.
    Haas JS; Kaplan CP; Des Jarlais G; Gildengoin V; Pérez-Stable EJ; Kerlikowske K
    J Womens Health (Larchmt); 2005 Nov; 14(9):845-51. PubMed ID: 16313212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summaries for patients. Alcohol, postmenopausal hormone therapy, and breast cancer.
    Ann Intern Med; 2002 Nov; 137(10):I43. PubMed ID: 12435234
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of lifestyle factors on gynaecological cancer.
    Rieck G; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):227-51. PubMed ID: 16543119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of baseline and updated information on alcohol intake on risk for breast cancer: importance of latency.
    Thygesen LC; Mørch LS; Keiding N; Johansen C; Grønbaek M
    Int J Epidemiol; 2008 Jun; 37(3):669-77. PubMed ID: 18390878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decline in breast-cancer incidence.
    Kliewer EV; Demers AA; Nugent ZJ
    N Engl J Med; 2007 Aug; 357(5):509-10; author reply 513. PubMed ID: 17674464
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormones and breast cancer.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Have we found the ultimate risk factor for breast cancer?
    Vogel VG; Taioli E
    J Clin Oncol; 2006 Apr; 24(12):1791-4. PubMed ID: 16567765
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C; Bourg F; Legeai J; Senoussi S
    Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 38. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological research on individual risk factors and their relevance for prevention initiatives].
    Franceschi S
    Epidemiol Prev; 1996; 20(2-3):128-30. PubMed ID: 8766297
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.